4.4 Article

An improved and efficient strategy for the total synthesis of a colistin-like peptide

Journal

TETRAHEDRON LETTERS
Volume 57, Issue 17, Pages 1885-1888

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.tetlet.2016.03.055

Keywords

Colistin; Antimicrobial peptide; Synthesis; Convergent method

Funding

  1. National Research Foundation (NRF)
  2. University of KwaZulu-Natal (South Africa)
  3. Asphen Pharmacare
  4. CICYT [CTQ2012-30930]
  5. Generalitat de Catalunya [2014 SGR 137]
  6. NRF-DST, SA

Ask authors/readers for more resources

Polymyxins have re-emerged as the last-line therapy for treatment against extremely multi-drug resistant Gram-negative bacteria, which pose a global threat to public health. Colistin is a polymyxin antibiotic which is effective against most Gram-negative bacteria. Herein, we report a facile and convenient synthesis of a colistin analogue. All the Dabs were protected as Boc groups except for Dab4 which was Alloc protected and used for cyclization with Thr10. The choice of Boc over other protecting groups was to enhance the solubility of the peptide. Cyclization in a volatile solvent such as DCM under very mild conditions and precipitation of the peptide using water are additional advantages of this protocol which can potentially be used for bulk production. The colistin analogue revealed good antibacterial activity in comparison to the natural version. (C) 2016 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules

Beatriz G. G. de la Torre, Fernando Albericio

Summary: While the world was battling with the COVID-19 Omicron wave at the end of 2021, except for China, most countries ended 2022 with COVID-19 being treated like the flu. As a result, the U.S. Food and Drug Administration (FDA) only authorized 37 new drugs this year, compared to an average of 52 in the previous four years. This marks the second lowest number of drug approvals in the last six years, even though it may change in the future. The decrease in FDA approvals mainly applies to small molecule drugs, while biologics and TIDES have remained relatively constant.

MOLECULES (2023)

Review Chemistry, Multidisciplinary

Reaction of 3-Acetylcoumarin: From methods to mechanism

Narges Hosseini Nasab, Fereshteh Azimian, Hendrik G. Kruger, Song Ja Kim

Summary: Coumarins, heterocyclic compounds with a benzo-a-pyrone structure, are widely used in pharmacology, cosmetics, chemical, and medicinal industries. Various methods and reactions have been employed to synthesize coumarin derivatives. This review covers the reactions of 3-acetylcoumarin with different reagents and provides an overview of various reactions of 3-acetylcoumarin, including multicomponent, cycloaddition, α-halogenation, aldol condensation, reduction, and 1,2-addition reactions. The synthesis of different compounds starting from 3-acetylcoumarins and their biological activities are presented. This review serves as a valuable resource for researchers in this field.

ARABIAN JOURNAL OF CHEMISTRY (2023)

Article Chemistry, Organic

N-Arylation of primary and tertiary sulfonimidamides (SIAs) with benzyne precursors under transition metal-free conditions

Srinivas Ambala, Kimberleigh B. Govender, Kamal K. Rajbongshi, Thavendran Govender, Hendrik G. Kruger, Tricia Naicker, Per I. Arvidsson

Summary: Here, an effective and efficient transition metal-free method for the N-arylation of primary sulfonimidamides was reported. The benzyne intermediates generated from silyl aryl triflates successfully coupled with the primary sulfonimidamides, resulting in good to excellent yields. In addition, by adding 18-crown-6, the scope of this method was extended to tertiary sulfonimidamides with moderate to low yields.

TETRAHEDRON LETTERS (2023)

Article Chemistry, Medicinal

In Vitro and In Vivo Development of a β-Lactam-Metallo-β- Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales

Byron K. Peters, Nakita Reddy, Mbongeni Shungube, Letisha Girdhari, Sooraj Baijnath, Sipho Mdanda, Lloyd Chetty, Thandokuhle Ntombela, Thilona Arumugam, Linda A. Bester, Sanil D. Singh, Anil Chuturgoon, Per I. Arvidsson, Glenn E. M. Maguire, Hendrik G. Kruger, Tricia Naicker, Thavendran Govender

Summary: Fi-lactams are the most commonly prescribed antibiotics due to their potent antimicrobial activities, but their efficacy is threatened by the alarming rates of antimicrobial resistance, particularly in carbapenem-resistant Enterobacterales expressing metallo-fi-lactamases (MBLs). In this study, a cyclic zinc chelator called BP1 was developed, which restored the efficacy of meropenem against MBL-expressing bacteria and showed no toxicity to human cells. The study also demonstrated the therapeutic potential of BP1 in reducing bacterial load in infected mice. These findings propose a promising strategy to combat antimicrobial resistance.

ACS INFECTIOUS DISEASES (2023)

Article Chemistry, Physical

A DFT study of the catalytic ODH of n-hexane over a cluster model of vanadium oxide

Nkululeko E. Damoyi, Holger B. Friedrich, Gert H. Kruger, David J. Willock

Summary: Supported vanadium oxides are widely used catalysts for the selective oxidative dehydrogenation of alkanes to alkenes. The activity of these catalysts is influenced by the different oxygen species involved, with singly coordinated vanadyl V(V)=O being the most reactive. Understanding the relative activity of different oxygen species can help improve catalyst design and enhance productivity and selectivity in the reaction.

MOLECULAR CATALYSIS (2023)

Article Infectious Diseases

Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel fi-Lactam-Metallo- β-Lactamase Inhibitors

Nakita Reddy, Letisha Girdhari, Mbongeni Shungube, Arnoldus C. Gouws, Byron K. Peters, Kamal K. Rajbongshi, Sooraj Baijnath, Sipho Mdanda, Thandokuhle Ntombela, Thilona Arumugam, Linda A. Bester, Sanil D. Singh, Anil Chuturgoon, Per I. Arvidsson, Glenn E. M. Maguire, Hendrik G. Kruger, Thavendran Govender, Tricia Naicker

Summary: This study evaluated the use of a novel beta-lactamase inhibitor, BP2, in combination with meropenem to overcome resistance in hard-to-treat infectious diseases caused by virulent bacteria expressing beta-lactamases. The results showed that BP2 enhanced the activity of meropenem, exhibiting bactericidal effects with a MIC of <= 1 mg/L and was safe to use at the tested concentrations. BP2 also demonstrated strong inhibitory activity against NDM-1 and VIM-2, specifically targeting MBLs. In a murine infection model, the combination of BP2 and meropenem showed significant efficacy. These promising pre-clinical results make BP2 a suitable candidate for further research and development as a metallo-beta-lactamase inhibitor (MBLI).

ANTIBIOTICS-BASEL (2023)

Article Chemistry, Multidisciplinary

Methionine-Containing Peptides: Avoiding Secondary Reactions in the Final Global Deprotection

K. P. Nandhini, Mahama Alhassan, Clinton G. L. Veale, Fernando Albericio, Beatriz G. de la Torre

Summary: The solid-phase synthesis of Met-containing peptides often leads to the formation of impurities, Met(O) and sulfonium salt, due to oxidation and S-alkylation reactions. These reactions occur during the final acidolytic cleavage step. In this study, two new cleavage solutions were developed to eliminate oxidation and reduce S-alkylation. The optimal mixture for Cys-containing peptides was TFA-anisole-TMSCl-Me2S-TIS with triphenyl phosphine, while TIS was not required for other peptides. Both cleavage solutions were effective for sensitive amino acids like Cys and Trp. The sulfonium salt was successfully reversed to free Met-containing peptide by heating with acetic acid.

ACS OMEGA (2023)

Review Biochemistry & Molecular Biology

FDA Approvals of Biologics in 2022

Alexander C. Martins, Fernando Albericio, Beatriz G. de la Torre

Summary: The year 2022 saw the successful control of the COVID-19 pandemic in most countries through social and hygiene measures and vaccination campaigns. However, there was a decrease in total drug approvals by the FDA, particularly for small molecules. The Biologics class, on the other hand, maintained its figures with the authorization of 15 novel molecules.

BIOMEDICINES (2023)

Article Biochemistry & Molecular Biology

Serinol-Based Versatile Disulfide-Reducing Reagent

Babita Kushwaha, Sinenhlanhla N. Mthembu, Anamika Sharma, Fernando Albericio, Beatriz G. de la Torre

Summary: We have synthesized disulfide-reducing agents DPDT and DMPDT from serinol and methyl serinol, respectively. DPDT demonstrated higher stability than DMPDT. The reducing capacity of DPDT was found to be comparable to that of DTT, and its effectiveness was evaluated in both liquid and solid phases.

MOLECULES (2023)

Article Chemistry, Multidisciplinary

Design, synthesis, and in vitro and in silico studies of 1,3,4-thiadiazole-thiazolidinone hybrids as carbonic anhydrase inhibitors

Narges Hosseini Nasab, Hussain Raza, Young Seok Eom, Mubashir Hassan, Andrzej Kloczkowski, Lloyd Christopher Chetty, Hendrik Gert Kruger, Song Ja Kim

Summary: A series of 1,3,4-thiadiazole-thiazolidinone derivatives (7a-j) were synthesized and evaluated as carbonic anhydrase inhibitors. Compound 7i showed higher inhibitory activity (IC50 = 0.402 +/- 0.017 mu M) compared to the standard reference acetazolamide (IC50 = 0.998 +/- 0.046 mu M). Kinetic analysis revealed that compound 7i binds competitively to the target enzyme. Compound 7i also exhibited good conformational state and hydrogen bond interactions in the receptor binding pocket, according to molecular docking studies.

NEW JOURNAL OF CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Synthesis and biological evaluation of novel blactam-metallo β-lactamase inhibitors

Mbongeni Shungube, Ayanda K. Hlophe, Letisha Girdhari, Victor T. Sabe, Byron B. Peters, Nakita Reddy, Kehinde F. Omolabi, Lloyd Chetty, Thilona Arumugam, Anil Chuturgoon, Hendrik G. Kruger, Per I. Arvidsson, Hua-Li Qin, Tricia Naicker, Thavendran Govender

Summary: Beta-lactamases deactivate beta-lactam antibiotics through hydrolysis mechanism. This study developed 11 potential MBL inhibitors that successfully restored the effectiveness of meropenem against NDM-producing Klebsiella pneumoniae infections.

RSC ADVANCES (2023)

Article Microbiology

The in vitro and in vivo potential of metal-chelating agents as metallo-beta-lactamase inhibitors against carbapenem-resistant Enterobacterales

Kehinde F. Omolabi, Nakita Reddy, Sipho Mdanda, Sphamandla Ntshangase, Sanil D. Singh, Hendrik G. Kruger, Tricia Naicker, Thavendran Govender, Sooraj Bajinath

Summary: The recent surge in beta-lactamase resistance has led to the emergence of superbugs, posing a significant threat to public healthcare. This study evaluated the potential of 1,4,7-triazacyclononane-1,4,7 triacetic acid (NOTA) as a metallo-beta-lactamase (MBL) inhibitor in combination with meropenem against MBL producing bacteria. The results showed that NOTA restored the efficacy of meropenem and significantly decreased the colony-forming units of carbapenem-resistant Klebsiella pneumoniae in a murine infection model.

FEMS MICROBIOLOGY LETTERS (2023)

Review Chemistry, Multidisciplinary

The challenge of peptide nucleic acid synthesis

K. P. Nandhini, Danah Al Shaer, Fernando Albericio, Beatriz G. G. de la Torre

Summary: Peptide Nucleic Acids (PNAs) are important mimics of DNA/RNA that can effectively bind with high affinity and specificity. Due to their metabolic stability, PNAs have broad applications in various fields. However, PNA synthesis faces challenges such as difficulties in preparing monomers and their solubility, as well as obstacles related to intra/inter chain aggregation and side reactions. Different protecting group strategies can be employed to overcome these hurdles and optimize the synthesis process.

CHEMICAL SOCIETY REVIEWS (2023)

Article Chemistry, Organic

A safety-catch protecting group strategy compatible with Boc-chemistry for the synthesis of peptide nucleic acids (PNAs)

K. P. Nandhini, Sikabwe Noki, Edikarlos Brasil, Fernando Albericio, Beatriz G. de la Torre

Summary: Peptide Nucleic Acids (PNAs) are a class of synthetic biomolecules with great potential in medicine. A new PNA SPS strategy based on a safety-catch protecting group scheme has been developed, allowing the synthesis of PNAs using Boc as a temporal protecting group.

ORGANIC & BIOMOLECULAR CHEMISTRY (2023)

Article Chemistry, Organic

Pyrrolidine-based C1-symmetric chiral transition metal complexes as catalysts in the asymmetric organic transformations

Geeta Devi Yadav, Pooja Chaudhary, Balaram Pani, Surendra Singh

Summary: Chiral transition metal complexes with privileged ligands are efficient catalysts for various asymmetric organic transformations. Transition metal complexes of C1-symmetric pyrrolidine-based ligands have been widely used in asymmetric organic reactions. However, a comprehensive review article on the transition metal complexes of chiral C1-symmetric pyrrolidine-based ligands derived from (L)-proline has not been published.

TETRAHEDRON LETTERS (2024)